![IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML](https://www.mdpi.com/ijms/ijms-21-00141/article_deploy/html/images/ijms-21-00141-g001.png)
IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML
![Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth](https://www.science.org/cms/10.1126/sciadv.aay2174/asset/6ba4d34f-c7ad-4402-8355-e3a23782c692/assets/graphic/aay2174-f1.jpeg)
Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
![The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling - Journal of Biological Chemistry The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e2634a40-c698-46c7-886d-2d0bbc8c528f/gr1_lrg.jpg)
The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling - Journal of Biological Chemistry
![IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML](https://www.mdpi.com/ijms/ijms-21-00141/article_deploy/html/images/ijms-21-00141-g002.png)
IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML
![Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability | Nature Communications Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-05692-6/MediaObjects/41467_2018_5692_Fig1_HTML.png)
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability | Nature Communications
![Frontiers | Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification | Molecular Biosciences Frontiers | Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification | Molecular Biosciences](https://www.frontiersin.org/files/Articles/707439/fmolb-08-707439-HTML/image_m/fmolb-08-707439-g003.jpg)
Frontiers | Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification | Molecular Biosciences
![IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML](https://www.mdpi.com/ijms/ijms-21-00141/article_deploy/html/images/ijms-21-00141-g003.png)
IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML
![Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? | Clinical Cancer Research Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/21/8/1819/F2.medium.gif)
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? | Clinical Cancer Research
![Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange | Nature Communications Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms16111/MediaObjects/41467_2017_Article_BFncomms16111_Fig1_HTML.jpg)
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange | Nature Communications
![Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation](https://www.science.org/cms/asset/7d51dee9-f62c-4133-8907-2877c99ff768/aar8371-f1.gif)